GlaxoSmithKline's consumer health business will be named Haleon following its planned spinoff and listing on the London Stock Exchange later this year, according to the drugmaker.

Haleon was formed in July 2019 through the merger of GlaxoSmithKline’s (GB:GSK) and Pfizer’s consumer healthcare businesses. Subsequently, in July 2022, GSK spun off Haleon as an independent ...

GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next month, with a listing for the new company on the London Stock Exchange set for 18 July.

Haleon (HLN) share price has retreated in the past few weeks, erasing some of the gains made earlier this year. Its London ...

Haleon is a global consumer health company based in the UK, focused on developing and marketing over-the-counter health products. The company was formed as a spin-off from GSK (GlaxoSmithKline ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

The KSE-100 index of Pakistan Stock Exchange (PSX) lost on Tuesday more than 400 points, weighed down by institutional profit ...

With professional experience that includes serving as a brand manager at GlaxoSmithKline’s consumer health care spinoff Haleon and an investment background, Raskas believes he’s in a good ...

2022 was a year of big changes at pharmaceutical giant GSK, with a new moniker—a shortening of its former name, GlaxoSmithKline—and the spinoff of its consumer business, which now operates ...

Ahsan Mehanti of Arif Habib Corporation said stocks hit an all-time high led by blue chip scrips on IMF calls for ...